Abstract | OBJECTIVE: To determine the prevalence of drugs for comprehensive management of preeclampsia in national essential medicine lists (EMLs) in low and middle income countries (LMICs) METHODS: RESULTS: In 91 EMLs obtained from 144 LMICs, the most commonly listed parenteral antihypertensive therapies were verapamil (63.7%), hydralazine (61.5%), sodium nitroprusside (48.3%), and propranolol (39.6%). The most prevalent oral antihypertensive therapies were nifedipine (95.6%), methyldopa (93.4%), propranolol (90.1%), and atenolol (87.9%). For eclampsia/ preeclampsia, magnesium sulphate was present in 84.6% of EMLs and calcium gluconate in 85.7%. For pulmonary edema, most EMLs (94.5%) listed oral furosemide, for thrombosis 92.3% listed heparin, for acceleration of fetal pulmonary maturity 90.1% listed parenteral dexamethasone, and for labour induction 97.8% listed oxytocin or a prostanoid (usually misoprostol, 40.7%). CONCLUSION: EMLs of LMICs provide comprehensive coverage of preeclampsia pharmacotherapy. These EMLs may be used as advocacy tools to ensure the availability of these therapies within each country.
|
Authors | Shifana Lalani, Tabassum Firoz, Laura A Magee, Diane Sawchuck, Beth Payne, Rebecca Gordon, Marianne Vidler, Peter von Dadelszen, Community Level Interventions for Pre-eclampsia (CLIP) Working Group |
Journal | Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC
(J Obstet Gynaecol Can)
Vol. 35
Issue 3
Pg. 215-223
(Mar 2013)
ISSN: 1701-2163 [Print] Netherlands |
PMID | 23470109
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antihypertensive Agents
- Diuretics
- Fibrinolytic Agents
- Glucocorticoids
- Oxytocics
- Tocolytic Agents
- Oxytocin
- Magnesium Sulfate
- Dexamethasone
- Heparin
- Betamethasone
|
Topics |
- Antihypertensive Agents
(therapeutic use)
- Betamethasone
(therapeutic use)
- Developing Countries
- Dexamethasone
(therapeutic use)
- Diuretics
(therapeutic use)
- Eclampsia
(drug therapy)
- Female
- Fibrinolytic Agents
(therapeutic use)
- Glucocorticoids
(therapeutic use)
- Heparin
(therapeutic use)
- Humans
- Magnesium Sulfate
(therapeutic use)
- Oxytocics
(therapeutic use)
- Oxytocin
(therapeutic use)
- Pre-Eclampsia
(drug therapy)
- Pregnancy
- Pulmonary Edema
(drug therapy, etiology)
- Thromboembolism
(drug therapy, etiology)
- Tocolytic Agents
(therapeutic use)
|